Oral hypoglycaemics - a review of the evidence.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Australian Family Physician

• Publication date

  2010-09-01

• Fields of study

  Medicine

• Identifiers
  PMID 20877770
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Glucose control and vascular complications in veterans with type 2 diabetes.

  2009cited by this paper
• Controversies in type 2 diabetes - An update.

  2009cited by this paper
• Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy

  2009cited by this paper
• Skeletal consequences of thiazolidinedione therapy

  2008cited by this paper
• 10-year follow-up of intensive glucose control in type 2 diabetes.

  2008cited by this paper
• Pioglitazone Use and Heart Failure in Patients With Type 2 Diabetes and Preexisting Cardiovascular Disease

  2007cited by this paper
• Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes.

  2007cited by this paper
• Long-term risk of cardiovascular events with rosiglitazone: a meta-analysis.

  2007cited by this paper
• Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials.

  2007cited by this paper

• ANTIHYPERGLYCAEMIC, ANTIHYPERLIPIDAEMIC AND ANTIHYPERTENSIVE EFFECT OF A POLYHERBAL FORMULATION IN ALLOXAN-INDUCED DIABETIC RATS

  2020cites this paper
• Evaluation of the Antihyperglycemic Effect of Minor Steviol Glycosides in Normoglycemic and Induced-Diabetic Wistar Rats

  2016cites this paper
• Antihyperglycemic Activity of Eucalyptus tereticornis in Insulin-Resistant Cells and a Nutritional Model of Diabetic Mice

  2015cites this paper
• Stevia rebaudiana Bertoni. Un potencial adyuvante en el tratamiento de la diabetes mellitus

  2014cites this paper
• Peptidomimetics as potent and selective PTP1B inhibitors.

  2013cites this paper
• 11 b-Hydroxysteroid dehydrogenase type 1 : potential therapeutic target for metabolic syndrome

  2012cites this paper
• Targeting Renal Glucose Reabsorption for the Treatment of Type 2 Diabetes Mellitus Using the SGLT2 Inhibitor Dapagliflozin

  2012cites this paper
• Kinetics Studies on the Inhibition Mechanism of Pancreatic α‐Amylase by Glycoconjugated 1H‐1,2,3‐Triazoles: A New Class of Inhibitors with Hypoglycemiant Activity

  2012cites this paper
• Investigations of Altered Proteome Dynamics in Calorie Restriction, Insulin Resistance and Type 2 Diabetes

  2012cites this paper
• Banaba: The natural remedy as antidiabetic drug

  2011influential citation
• Novel therapies for resistant focal segmental glomerulosclerosis (FONT) phase II clinical trial: study design

  2011cites this paper
• Clinical drugs undergoing polymorphic metabolism by human cytochrome P450 2C9 and the implication in drug development.

  2011cites this paper
• Protection of pancreatic beta cellsby rosiglitazone - mechanisms and pathways

  2011cites this paper
• STRUKTURA, DZIA£ANIE I ROLA RECEPTORA- GAMMA PEROKSYSOMÓW AKTYWOWANEGO

  year unknowncites this paper